Management of Occupational and Nonoccupational HIV Exposure
Summary
- PEP failures significant because of likelihood that antiretroviral resistance mutations will develop as result of drug exposure
- Among 2-drug regimens, lamivudine-associated M184V resistance mutation earliest to develop
- Timing of additional mutations depends on how long patient allowed to remain on treatment after M184V emerges
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content